TITLE

Obesity is associated with higher 4E-BP1 expression in endometrial cancer

AUTHOR(S)
Libby, Emily Falk; Azrad, Maria; Novak, Lea; Vazquez, Ana I.; Wilson, Tamara R.; Demark-Wahnefried, Wendy
PUB. DATE
January 2014
SOURCE
Current Biomarker Findings;2014, Vol. 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: Obesity is associated with risk and prognosis of endometrial cancer (EC), and the mammalian target of rapamycin complex 1 (mTORC1) pathway may play an instrumental role. We sought to explore the associations between cellular proliferation, Akt, and 4E binding protein-1 (4E-BP1) (a downstream target of mTORC1), in obese and nonobese women with and without EC. Methods: Archival tissue-specimens from endometrial biopsies were grouped into two broad categories based on the observed disease behavior and similarities in tissue staining patterns: benign/hyperplasia (without cytologic atypia) (n=18) versus atypia (complex hyperplasia with cytologic atypia)/carcinoma (n=25). The characteristics of the study population, including height and weight to determine body mass index (BMI: kg/m2), were abstracted from medical records. Immunohistochemistry was used to assess the phosphorylated (p)Akt, p4E-BP1, and antigen Ki67. Results: Cytoplasmic and nuclear pAkt were significantly associated with cytoplasmic p4E-BP1 (β=+0.48, β=+0.50) (P<0.05) and nuclear p4E-BP1 (β=+0.40, β=+0.44) (P<0.05); cytoplasmic and nuclear p4E-BP1 were significantly associated with Ki67 (β=+0.46, β=+0.59) (P<0.05). Compared with the benign/hyperplasia group, the women with atypia/carcinoma had significantly higher cytoplasmic and nuclear p4E-BP1 and Ki67. This staining pattern was similar in obese women; however, in nonobese women, neither cytoplasmic nor nuclear p4E-BP1staining differed between benign/hyperplasia versus atypia/carcinoma. Conclusion: The activation of 4E-BP1 was higher in the obese women with EC. Adiposity may be a key factor to consider in future studies investigating the role of 4E-BP1 as a biomarker and therapeutic target in EC.
ACCESSION #
94734004

 

Related Articles

  • Obesity and gynaecological cancer. Lane, Geoffrey // Menopause International;Mar2008, Vol. 14 Issue 1, p33 

    Obesity is now considered to be a global epidemic. The problem of obesity has significant implications for the diagnosis and treatment of gynaecological cancer. The cancer most frequently associated with obesity is that of the endometrium. The risk of endometrial cancer is 2-3 times higher in...

  • Expression of Estrogen Receptors (α, β), Cyclooxygenase-2 and Aromatase in normal endometrium and endometrioid cancer of uterus. Knapp, P.; Chabowski, A.; Błachnio-Zabielska, A.; Walentowicz-Sadłecka, M.; Grabiec, M.; Knapp, P. A. // Advances in Medical Sciences (De Gruyter Open);2013, Vol. 58 Issue 1, p96 

    Purpose: Endometrial cancer (EC) is one of the most common malignancies of the female genital tract, but the etiology, especially its metabolism is still investigated. The aim of this study was to evaluate the presence and relative expression of Estrogen Receptors (α, β), Cyclooxygenase-2...

  • Obesity and endometrial cancer survival: a systematic review. Arem, H; Irwin, M L // International Journal of Obesity;May2013, Vol. 37 Issue 5, p634 

    Although it is known that obesity increases the risk of endometrial cancer and is linked to higher mortality rates in the general population, the association between obesity and mortality among endometrial cancer survivors is unclear. We performed a medline search using exploded Mesh keywords...

  • Extra Weight Adds Cancer Risk.  // USA Today Magazine;Feb2002, Vol. 130 Issue 2681, p12 

    Reports on the risk of developing cancer by obese persons. Breast cancer; Colorectal cancer; Endometrial cancer; Prostate cancer; Kidney cancer; Cancer of the esophagus; Disease associations; Disease development.

  • Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro. Darb-Esfahani, Silvia; Faggad, Areeg; Noske, Aurelia; Weichert, Wilko; Buckendahl, Ann-Christin; Muller, Berit; Budczies, Jan; Röske, Annika; Dietel, Manfred; Denkert, Carsten // Journal of Cancer Research & Clinical Oncology;Jul2009, Vol. 135 Issue 7, p933 

    Endometrial adenocarcinoma, due to a frequent activation of PI3 K/AKT has been proposed as a candidate neoplasm for the treatment with mTOR inhibitors. Yet, data on the expression of mTOR cascade components in endometrial cancer are lacking. To provide a basis for futher studies with mTOR...

  • Reprodüktif Dönemde Anormal Uterin Kanaması Olan Kadınlarda Endometrial Poliplerin Obezite, Diyabet ve Hipertansiyon Sıklığı ile Ä°liÅŸkisi. Yücel, Burak; Seçkin, Kerem Doğa; Özköse, Burak; Aydın, Turgut; Ekiz, Ali; Yıldırım, Gökhan // Kafkas Journal of Medical Sciences, Kafkas Tip Bilimleri Dergisi;2017, Vol. 7 Issue 1, p11 

    Aim: To investigate whether endometrial polyps are associated with obesity and incidence of diabetes mellitus or hypertension in women who admitted with abnormal uterin bleeding in reproductive ages. Material and Method: We included 557 patients who had endometrial sampling due to the abnormal...

  • Noncontraceptive estrogens and abnormalities of endometrial proliferation. Weiss, Noel S.; Weiss, N S // Annals of Internal Medicine;Mar78, Vol. 88 Issue 3, p410 

    Use of estrogen preparations among menopausal women has been causally associated with the development of hyperplasia and adenocarcinoma of the endometrium. The magnitude of the association seems to be greater for the hyperplastic and least aggressive malignant lesions, and smaller for tumors of...

  • Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance. Sun, Jian; Luo, Yixi; Tian, Zhen; Gu, Liang; Xia, Shu Chi; Yu, Youcheng // BMC Cancer;2012, Vol. 12 Issue 1, p499 

    Background: ERBB3 binding protein 1 (EBP1) gene transfer into human salivary adenoid cystic carcinoma cells has been shown to significantly inhibit cell proliferation and reduce tumor metastasis in mouse models. In the current study, to evaluate if EBP1 is a novel biomarker capable of...

  • Expression and significance of biglycan in endometrial cancer. Liu, Yang; Li, Weihua; Li, Xin; Tai, Yanhong; Lü, Qingtao; Yang, Ning; Jiang, Jie // Archives of Gynecology & Obstetrics;Mar2014, Vol. 289 Issue 3, p649 

    Objective: This study aimed to determine the expression level of biglycan in different lesion properties of endometrium and to investigate the possible function and prognostic value of biglycan in endometrial cancer. Methods: Immunohistochemical staining (IHC) and quantitative realtime reverse...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics